ZIVO Bioscience has received $1 million in bridge funding
Zivo Bioscience Inc., a biotech/agtech R&D company focused on the development of therapeutic, medicinal, and nutritional product candidates derived from proprietary algal cultures, announced today that its Chairman, Chief Executive Officer, and President, John Payne, has provided a $1 million unsecured six-month loan. The loan has a 10% simple interest rate, can be repaid without … Read more